Tune into our bi-monthly podcast where we interview experts in the field to broaden the awareness of new HCM studies & advancements!

In the Thick of It
Claim This Podcastby Hypertrophic Cardiomyopathy Medical Society
Podcast Authority
Beta
Podcast Overview
Tune into our bi-monthly podcast where we interview experts in the field to broaden the awareness of new HCM studies & advancements!
Language
🇺🇲
Publishing Since
6/28/2023
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for In the Thick of It
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

June 2, 2026
Long-Term Realities: Managing Disease Progression and ICD Selection in Young HCM Patients
<p>Patient advocates Hannah and Bethany Keime from HeartCharged sit down with Dr. John Fritzlen to discuss the long-term journey of living with hypertrophic cardiomyopathy (HCM). The conversation covers the progressive nature of the condition, including the onset of heart failure symptoms, atrial fibrillation, and myocardial remodeling over decades, as well as how advanced diagnostics like cardiopulmonary exercise testing (CPET) help clinicians track subtle declines. Dr. Fritzlen shares tailored approaches for counseling young or newly diagnosed patients, emphasizing the importance of active lifestyle management and proactive treatment strategies like cardiac myosin inhibitors. Additionally, the group addresses the critical clinical and lifestyle factors involved in selecting implantable cardioverter-defibrillators (ICDs), detailing the durability advantages of subcutaneous (S-ICD) and extravascular (EV-ICD) systems for active, younger populations.</p>

May 5, 2026
Reevaluating Beta Blockers: New Evidence in Non-Obstructive HCM Care
<p>Dr. Florian Rader joins Dr. Louise Bjerregaard to discuss a groundbreaking randomized, double-blind, triple-crossover trial that challenges the long-standing "mantra" of using beta blockers as first-line therapy for non-obstructive hypertrophic cardiomyopathy (HCM). Dr. Bjerregaard explains how the study compared bisoprolol, verapamil, and placebo, revealing that bisoprolol actually resulted in a significant reduction in functional capacity and a worsening of patient symptoms as measured by the KCCQ score. The conversation explores why slowing the heart rate may be detrimental to patients with "stiff hearts" who rely on chronotropic competence to maintain cardiac output, and why calcium channel blockers like verapamil might be a more favorable alternative for symptom management. This episode is essential listening for clinicians looking to move beyond expert opinion toward evidence-based, personalized care for their non-obstructive HCM patients.</p><p>View the results of the trial here: https://www.jacc.org/doi/10.1016/j.jacc.2025.11.028</p>

April 24, 2026
The ODYSSEY Continues: Deep Diving into Non-Obstructive HCM Data
<p>Dr. James MacNamara welcomes Dr. Milind Desai from the Cleveland Clinic to dissect the results and implications of the ODYSSEY trial, the largest study ever conducted in hypertrophic cardiomyopathy (HCM). The trial investigated the use of mavacamten in patients with non-obstructive HCM, a population with significant unmet medical needs. While the study did not reach statistical significance for its primary endpoints of KCCQ score and peak VO2, Dr. Desai highlights a powerful "rowing in the same direction" effect seen in secondary data. This includes a 53% reduction in cardiac biomarkers (BNP and troponin) and favorable cardiac remodeling observed on echocardiography. The conversation explores why a strong placebo effect may have impacted the results and identifies a specific "sweet spot" responder group: patients with an ejection fraction above 65% and no history of atrial tachyarrhythmias.</p><p><strong>References:<br></strong>ODYSSEY Subgroup Analysis: <a href="https://www.jacc.org/doi/10.1016/j.jacc.2025.12.092">https://www.jacc.org/doi/10.1016/j.jacc.2025.12.092</a></p><p>ODYSSEY Exploratory Analyses: <a href="https://www.jacc.org/doi/10.1016/j.jacc.2025.12.092">https://www.jacc.org/doi/10.1016/j.jacc.2025.12.092</a></p><p>ODYSSEY-HCM Trial: <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2505927">https://www.nejm.org/doi/full/10.1056/NEJMoa2505927</a></p>
36 total episodes available
Similar Podcasts
Discover related shows you might enjoy

Tales from the Heart
Hypertrophic Cardiomyopathy Association / Lisa Salberg

Cardionerds: A Cardiology Podcast
CardioNerds

This Week in Cardiology
Medscape

Eagle's Eye View: Your Weekly CV Update From ACC.org
American College of Cardiology

The Ezra Klein Show
New York Times Opinion

Fresh Air
NPR

The Jon Stewart Podcast
Comedy Central

Planet Money
NPR

The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast

The Daily
The New York Times

Up First
NPR

Pod Save America
Pod Save America

The Mel Robbins Podcast
Mel Robbins

Criminal
Vox Media Podcast Network

White Coat Investor Podcast
Dr. Jim Dahle of the White Coat Investor
Deep-dive analytics for In the Thick of It
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is In the Thick of It?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.